Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.
Erythromycin is the drug of choice for treatment of Mycoplasma pneumoniae infections due to its susceptibility to low levels of this antibiotic. After exposure of susceptible strains to erythromycin in vitro and in vivo, mutants resistant to erythromycin and other macrolides were isolated. Their phe...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1995
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163027/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8593017/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.12.2770 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|